UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas

Clinical cancer research, 2015-12, Vol.21 (24), p.5519-5531

2015

Volltextzugriff (PDF)

The Stromal and Immune Landscape of Colorectal Cancer Progression during Anti-EGFR Therapy

Cancer cell, 2019-07, Vol.36 (1), p.1-3

2019

Volltextzugriff (PDF)

Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga

Trends in cancer, 2019-12, Vol.5 (12), p.779-788

2019

Volltextzugriff (PDF)

Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin

Nature biotechnology, 2022-02, Vol.40 (2), p.235-244

2022

Volltextzugriff (PDF)

Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer

Clinical cancer research, 2023-03, Vol.29 (6), p.1102-1113

2023

Volltextzugriff (PDF)

Abstract 309: Targeting anti-apoptotic reprogramming to counteract drug tolerance in EGFR-inhibited colorectal tumors

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.309-309

2018

Volltextzugriff (PDF)

Abstract 659: Sustained inhibition of HER3 and EGFR is necessary to induce regression of HER2-amplified gastrointestinal carcinomas

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.659-659

2015

Volltextzugriff (PDF)

Abstract B43: HER2-amplified gastric and colorectal cancers: Mechanistic insights into HER2 targeting approaches

Clinical cancer research, 2015-02, Vol.21 (4_Supplement), p.B43-B43

2015

Volltextzugriff (PDF)

Abstract 3697: Exploiting patient-derived xenografts and organoids to tackle apoptotic dependencies in EGFR-inhibited colorectal tumours

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3697-3697

2022

Volltextzugriff (PDF)

The redox-active nanomaterial toolbox for cancer therapy

Cancer letters, 2015-04, Vol.359 (1), p.9-19

2015

Volltextzugriff (PDF)

EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma

International journal of molecular sciences, 2020-07, Vol.21 (14), p.4856

2020

Volltextzugriff (PDF)

Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-11, Vol.23 (6), p.1064-1074

2020

Volltextzugriff (PDF)

Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

Journal of clinical oncology, 2007-04, Vol.25 (10), p.1247-1254

2007

Volltextzugriff (PDF)

In Vivo Comparison of Micro-Balloon Interventions (MBI) Advantage: A Retrospective Cohort Study of DEB-TACE Versus b-TACE and of SIRT Versus b-SIRT

Cardiovascular and interventional radiology, 2022-03, Vol.45 (3), p.306-314

2022

Volltextzugriff (PDF)

Obesity, Pregnancy and the Social Contract with Today’s Adolescents

Nutrients, 2022-08, Vol.14 (17), p.3550

2022

Volltextzugriff (PDF)

Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?

Cancer chemotherapy and pharmacology, 2024, Vol.93 (1), p.1-9

2024

Volltextzugriff (PDF)

Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population

Scientific reports, 2020-01, Vol.10 (1), p.144, Article 144

2020

Volltextzugriff (PDF)

Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy

Journal of gastrointestinal cancer, 2023-09, Vol.54 (3), p.802-808

2023

Volltextzugriff (PDF)

HRP-4 Walks on Soft Feet

IEEE robotics and automation letters, 2021-04, Vol.6 (2), p.470-477

2021

Volltextzugriff (PDF)

Dietary iron intake and anemia: food frequency questionnaire in patients with hereditary hemorrhagic telangiectasia

Orphanet journal of rare diseases, 2020-10, Vol.15 (1), p.1-295, Article 295

2020

Volltextzugriff (PDF)

Are fascial strains involved in chronic pelvic pain syndrome etiology? A case-control study

Journal of bodywork and movement therapies, 2023-01, Vol.33, p.e54-e54

2023

Volltextzugriff (PDF)

Potential Benefits of Holmium-166 Radioembolization as a Neoadjuvant Treatment of Intrahepatic Cholangiocarcinoma

Cardiovascular and interventional radiology, 2021-02, Vol.44 (2), p.345-347

2021

Volltextzugriff (PDF)

The specialized pediatric palliative care service in Italy: how is it working? Results of the nationwide PalliPed study

Italian journal of pediatrics, 2024-03, Vol.50 (1), p.55-55, Article 55

2024

Volltextzugriff (PDF)

Are fascial strains involved in chronic pelvic pain syndrome? An exploratory matched case–control study

International urology and nephrology, 2023-03, Vol.55 (3), p.511-518

2023

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(70)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas

The Stromal and Immune Landscape of Colorectal Cancer Progression during Anti-EGFR Therapy

Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga

Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin

Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer

Abstract 309: Targeting anti-apoptotic reprogramming to counteract drug tolerance in EGFR-inhibited colorectal tumors

Abstract 659: Sustained inhibition of HER3 and EGFR is necessary to induce regression of HER2-amplified gastrointestinal carcinomas

Abstract B43: HER2-amplified gastric and colorectal cancers: Mechanistic insights into HER2 targeting approaches

Abstract 3697: Exploiting patient-derived xenografts and organoids to tackle apoptotic dependencies in EGFR-inhibited colorectal tumours

The redox-active nanomaterial toolbox for cancer therapy

EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma

Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab

Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

In Vivo Comparison of Micro-Balloon Interventions (MBI) Advantage: A Retrospective Cohort Study of DEB-TACE Versus b-TACE and of SIRT Versus b-SIRT

Obesity, Pregnancy and the Social Contract with Today’s Adolescents

Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?

Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population

Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy

HRP-4 Walks on Soft Feet

Dietary iron intake and anemia: food frequency questionnaire in patients with hereditary hemorrhagic telangiectasia

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients

Are fascial strains involved in chronic pelvic pain syndrome etiology? A case-control study

Potential Benefits of Holmium-166 Radioembolization as a Neoadjuvant Treatment of Intrahepatic Cholangiocarcinoma

The specialized pediatric palliative care service in Italy: how is it working? Results of the nationwide PalliPed study

Are fascial strains involved in chronic pelvic pain syndrome? An exploratory matched case–control study

Suchergebnisse filtern